{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T21:50:36Z","timestamp":1793829036028,"version":"4.6.1"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,8]],"date-time":"2025-03-08T00:00:00Z","timestamp":1741392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,8]],"date-time":"2025-03-08T00:00:00Z","timestamp":1741392000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Biol"],"DOI":"10.1038\/s42003-025-07820-7","type":"journal-article","created":{"date-parts":[[2025,3,8]],"date-time":"2025-03-08T12:27:11Z","timestamp":1741436831000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Effector CD8 T cell differentiation in primary and breakthrough SARS-CoV-2 infection in mice"],"prefix":"10.1038","volume":"8","author":[{"given":"Brock","family":"Kingstad-Bakke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Woojong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Boyd L.","family":"Yount","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Cleven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongtae","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy A.","family":"Sullivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6827-8701","authenticated-orcid":false,"given":"Ralph C.","family":"Baric","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1794-3358","authenticated-orcid":false,"given":"M.","family":"Suresh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,8]]},"reference":[{"key":"7820_CR1","unstructured":"World Health Organization. data.who.int, WHO Coronavirus (COVID-19) dashboard > Cases. (2023)."},{"key":"7820_CR2","unstructured":"Centers for Disease Control and Prevention. COVID Data Tracker. Atlanta, GA: U.S. Department of Health and Human Services, CDC. https:\/\/www.ebi.ac.uk\/ega\/ (2024)."},{"key":"7820_CR3","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1126\/science.abn7591","volume":"375","author":"A Muik","year":"2022","unstructured":"Muik, A. et al. Neutralization of SARS-CoV-2 Omicron by BNT162b2 mRNA vaccine-elicited human sera. Science 375, 678\u2013680 (2022).","journal-title":"Science"},{"key":"7820_CR4","doi-asserted-by":"crossref","unstructured":"Garcia-Beltran, W.F. et al. mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant. Cell 185, 457\u2013466.e454 (2022).","DOI":"10.1016\/j.cell.2021.12.033"},{"key":"7820_CR5","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1038\/s41586-022-04460-3","volume":"603","author":"R Keeton","year":"2022","unstructured":"Keeton, R. et al. T cell responses to SARS-CoV-2 spike cross-recognize Omicron. Nature 603, 488\u2013492 (2022).","journal-title":"Nature"},{"key":"7820_CR6","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1038\/s41577-020-0402-6","volume":"20","author":"Z Chen","year":"2020","unstructured":"Chen, Z. & John Wherry, E. T cell responses in patients with COVID-19. Nat. Rev. Immunol. 20, 529\u2013536 (2020).","journal-title":"Nat. Rev. Immunol."},{"key":"7820_CR7","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abd2071","volume":"5","author":"D Weiskopf","year":"2020","unstructured":"Weiskopf, D. et al. Phenotype and kinetics of SARS-CoV-2-specific T cells in COVID-19 patients with acute respiratory distress syndrome. Sci. Immunol. 5, eabd2071 (2020).","journal-title":"Sci. Immunol."},{"key":"7820_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17292-4","volume":"11","author":"S De Biasi","year":"2020","unstructured":"De Biasi, S. et al. Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia. Nat. Commun. 11, 3434 (2020).","journal-title":"Nat. Commun."},{"key":"7820_CR9","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/j.immuni.2021.03.005","volume":"54","author":"P. A Szabo","year":"2021","unstructured":"Szabo, P. A. et al. Longitudinal profiling of respiratory and systemic immune responses reveals myeloid cell-driven lung inflammation in severe COVID-19. Immunity 54, 797\u2013814 e796 (2021).","journal-title":"Immunity"},{"key":"7820_CR10","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1016\/j.cell.2022.01.029","volume":"185","author":"V Naranbhai","year":"2022","unstructured":"Naranbhai, V. et al. T cell reactivity to the SARS-CoV-2 Omicron variant is preserved in most but not all individuals. Cell 185, 1041\u20131051.e1046 (2022).","journal-title":"Cell"},{"key":"7820_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2020.100081","volume":"1","author":"J Neidleman","year":"2020","unstructured":"Neidleman, J. et al. SARS-CoV-2-Specific T cells exhibit phenotypic features of helper function, lack of terminal differentiation, and high proliferation potential. Cell Rep. Med. 1, 100081 (2020).","journal-title":"Cell Rep. Med."},{"key":"7820_CR12","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/s41586-021-04280-x","volume":"602","author":"S Adamo","year":"2022","unstructured":"Adamo, S. et al. Signature of long-lived memory CD8(+) T cells in acute SARS-CoV-2 infection. Nature 602, 148\u2013155 (2022).","journal-title":"Nature"},{"key":"7820_CR13","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2118312119","volume":"119","author":"B Kingstad-Bakke","year":"2022","unstructured":"Kingstad-Bakke, B. et al. Vaccine-induced systemic and mucosal T cell immunity to SARS-CoV-2 viral variants. Proc. Natl Acad. Sci. USA 119, e2118312119 (2022).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"7820_CR14","doi-asserted-by":"publisher","first-page":"e172510","DOI":"10.1172\/jci.insight.172510","volume":"8","author":"B Kingstad-Bakke","year":"2023","unstructured":"Kingstad-Bakke, B. et al. Airway surveillance and lung viral control by memory T cells induced by COVID-19 mRNA vaccine. JCI Insight 8, e172510 (2023).","journal-title":"JCI Insight"},{"key":"7820_CR15","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.immuni.2018.02.010","volume":"48","author":"S. C Jameson","year":"2018","unstructured":"Jameson, S. C. & Masopust, D. Understanding Subset Diversity in T Cell Memory. Immunity 48, 214\u2013226 (2018).","journal-title":"Immunity"},{"key":"7820_CR16","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1146\/annurev-immunol-042617-053214","volume":"37","author":"D Masopust","year":"2019","unstructured":"Masopust, D. & Soerens, A. G. Tissue-Resident T cells and other resident leukocytes. Annu. Rev. Immunol. 37, 521\u2013546 (2019).","journal-title":"Annu. Rev. Immunol."},{"key":"7820_CR17","doi-asserted-by":"publisher","first-page":"eaaw1217","DOI":"10.1126\/sciimmunol.aaw1217","volume":"4","author":"Z Wang","year":"2019","unstructured":"Wang, Z. et al. PD-1(hi) CD8(+) resident memory T cells balance immunity and fibrotic sequelae. Sci. Immunol. 4, eaaw1217 (2019).","journal-title":"Sci. Immunol."},{"key":"7820_CR18","doi-asserted-by":"publisher","first-page":"148.141","DOI":"10.4049\/jimmunol.196.Supp.148.1","volume":"196","author":"A Dutta","year":"2016","unstructured":"Dutta, A, et al. LAG-3 expressing antigen-specific CD4+ T cells attenuate lung inflammation during acute influenza virus infection. J. Immunol. 196, 148.141 (2016).","journal-title":"J. Immunol."},{"key":"7820_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15025-1","volume":"11","author":"M Schorer","year":"2020","unstructured":"Schorer, M. et al. TIGIT limits immune pathology during viral infections. Nat. Commun. 11, 1288 (2020).","journal-title":"Nat. Commun."},{"key":"7820_CR20","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/j.cmet.2020.09.007","volume":"32","author":"R. M Evans","year":"2020","unstructured":"Evans, R. M. & Lippman, S. M. Shining Light on the COVID-19 Pandemic: a Vitamin D receptor checkpoint in defense of unregulated wound healing. Cell Metab. 32, 704\u2013709 (2020).","journal-title":"Cell Metab."},{"key":"7820_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22210-3","volume":"12","author":"M Ferreira-Gomes","year":"2021","unstructured":"Ferreira-Gomes, M. et al. SARS-CoV-2 in severe COVID-19 induces a TGF-\u03b2-dominated chronic immune response that does not target itself. Nat. Commun. 12, 1961 (2021).","journal-title":"Nat. Commun."},{"key":"7820_CR22","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1038\/s41590-019-0478-y","volume":"20","author":"T. H Mann","year":"2019","unstructured":"Mann, T. H. & Kaech, S. M. Tick-TOX, it\u2019s time for T cell exhaustion. Nat. Immunol. 20, 1092\u20131094 (2019).","journal-title":"Nat. Immunol."},{"key":"7820_CR23","doi-asserted-by":"publisher","first-page":"2826","DOI":"10.3389\/fimmu.2018.02826","volume":"9","author":"Y Chen","year":"2018","unstructured":"Chen, Y., Zander, R., Khatun, A., Schauder, D. M. & Cui, W. Transcriptional and epigenetic regulation of effector and memory CD8 T cell differentiation. Front. Immunol. 9, 2826 (2018).","journal-title":"Front. Immunol."},{"key":"7820_CR24","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1084\/jem.20170494","volume":"214","author":"D Fang","year":"2017","unstructured":"Fang, D. & Zhu, J. Dynamic balance between master transcription factors determines the fates and functions of CD4 T cell and innate lymphoid cell subsets. J. Exp. Med. 214, 1861\u20131876 (2017).","journal-title":"J. Exp. Med."},{"key":"7820_CR25","doi-asserted-by":"publisher","first-page":"13236","DOI":"10.1073\/pnas.1711160114","volume":"114","author":"T Ciucci","year":"2017","unstructured":"Ciucci, T., Vacchio, M. S. & Bosselut, R. A STAT3-dependent transcriptional circuitry inhibits cytotoxic gene expression in T cells. Proc. Natl Acad. Sci. USA 114, 13236\u201313241 (2017).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"7820_CR26","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.cmet.2019.10.013","volume":"31","author":"C Zhang","year":"2020","unstructured":"Zhang, C. et al. STAT3 activation-induced fatty acid oxidation in CD8(+) T effector cells is critical for obesity-promoted breast tumor growth. Cell Metab. 31, 148\u2013161 e145 (2020).","journal-title":"Cell Metab."},{"key":"7820_CR27","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.3390\/cancers11121832","volume":"11","author":"G Verdeil","year":"2019","unstructured":"Verdeil, G., Lawrence, T., Schmitt-Verhulst, A. M. & Auphan-Anezin, N. Targeting STAT3 and STAT5 in tumor-associated immune cells to improve immunotherapy. Cancers11, 1832 (2019).","journal-title":"Cancers"},{"key":"7820_CR28","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/s41584-020-00571-1","volume":"17","author":"D McGonagle","year":"2021","unstructured":"McGonagle, D., Ramanan, A. V. & Bridgewood, C. Immune cartography of macrophage activation syndrome in the COVID-19 era. Nat. Rev. Rheumatol. 17, 145\u2013157 (2021).","journal-title":"Nat. Rev. Rheumatol."},{"key":"7820_CR29","doi-asserted-by":"crossref","unstructured":"Gordon, A. C., Angus, D. C. & Derde, L. P. G. Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19. Reply. N. Engl. J. Med. 385, 1147\u20131149 (2021).","DOI":"10.1056\/NEJMc2108482"},{"key":"7820_CR30","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.1056\/NEJMe2032071","volume":"383","author":"E Huang","year":"2020","unstructured":"Huang, E. & Jordan, S. C. Tocilizumab for Covid-19 - The Ongoing Search for effective therapies. N. Engl J. Med. 383, 2387\u20132388 (2020).","journal-title":"N. Engl J. Med."},{"key":"7820_CR31","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s41232-020-00146-3","volume":"40","author":"S Hojyo","year":"2020","unstructured":"Hojyo, S. et al. How COVID-19 induces cytokine storm with high mortality. Inflamm. Regen. 40, 37 (2020).","journal-title":"Inflamm. Regen."},{"key":"7820_CR32","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1016\/S2213-2600(20)30404-5","volume":"8","author":"D. E Leisman","year":"2020","unstructured":"Leisman, D. E. et al. Cytokine elevation in severe and critical COVID-19: a rapid systematic review, meta-analysis, and comparison with other inflammatory syndromes. Lancet Respir. Med. 8, 1233\u20131244 (2020).","journal-title":"Lancet Respir. Med."},{"key":"7820_CR33","doi-asserted-by":"publisher","first-page":"102537","DOI":"10.1016\/j.autrev.2020.102537","volume":"19","author":"D McGonagle","year":"2020","unstructured":"McGonagle, D., Sharif, K., O\u2019Regan, A. & Bridgewood, C. The Role of Cytokines including Interleukin-6 in COVID-19 induced Pneumonia and Macrophage Activation Syndrome-Like Disease. Autoimmun. Rev. 19, 102537 (2020).","journal-title":"Autoimmun. Rev."},{"key":"7820_CR34","doi-asserted-by":"publisher","first-page":"613422","DOI":"10.3389\/fimmu.2021.613422","volume":"12","author":"A Santa Cruz","year":"2021","unstructured":"Santa Cruz, A. et al. Interleukin-6 is a biomarker for the development of fatal severe acute respiratory syndrome Coronavirus 2 Pneumonia. Front. Immunol. 12, 613422 (2021).","journal-title":"Front. Immunol."},{"key":"7820_CR35","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.immuni.2020.12.002","volume":"54","author":"M.-S Rha","year":"2021","unstructured":"Rha, M.-S. et al. PD-1-Expressing SARS-CoV-2-Specific CD8+ T cells are not exhausted, but functional in patients with COVID-19. Immunity 54, 44\u201352.e43 (2021).","journal-title":"Immunity"},{"key":"7820_CR36","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/s41423-020-0402-2","volume":"17","author":"M Zheng","year":"2020","unstructured":"Zheng, M. et al. Functional exhaustion of antiviral lymphocytes in COVID-19 patients. Cell Mol. Immunol. 17, 533\u2013535 (2020).","journal-title":"Cell Mol. Immunol."},{"key":"7820_CR37","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1016\/j.immuni.2020.07.026","volume":"53","author":"R Zhou","year":"2020","unstructured":"Zhou, R. et al. Acute SARS-CoV-2 infection impairs dendritic cell and T cell responses. Immunity 53, 864\u2013877.e865 (2020).","journal-title":"Immunity"},{"key":"7820_CR38","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1038\/s41591-020-0944-y","volume":"26","author":"A. J Wilk","year":"2020","unstructured":"Wilk, A. J. et al. A single-cell atlas of the peripheral immune response in patients with severe COVID-19. Nat. Med. 26, 1070\u20131076 (2020).","journal-title":"Nat. Med."},{"key":"7820_CR39","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.cmet.2020.07.015","volume":"32","author":"A. C Codo","year":"2020","unstructured":"Codo, A. C. et al. Elevated glucose levels favor SARS-CoV-2 Infection and monocyte response through a HIF-1\u03b1\/Glycolysis-Dependent Axis. Cell Metab. 32, 498\u2013499 (2020).","journal-title":"Cell Metab."},{"key":"7820_CR40","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.immuni.2020.12.002","volume":"54","author":"M. S Rha","year":"2021","unstructured":"Rha, M. S. et al. PD-1-Expressing SARS-CoV-2-Specific CD8(+) T cells are not exhausted, but functional in patients with COVID-19. Immunity 54, 44\u201352.e43 (2021).","journal-title":"Immunity"},{"key":"7820_CR41","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1111\/j.1749-6632.2009.04911.x","volume":"1171","author":"B. B Aggarwal","year":"2009","unstructured":"Aggarwal, B. B. et al. Signal transducer and activator of transcription-3, inflammation, and cancer: how intimate is the relationship? Ann. N. Y. Acad. Sci. 1171, 59\u201376 (2009).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"7820_CR42","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1182\/blood-2013-07-517987","volume":"123","author":"D. M Hossain","year":"2014","unstructured":"Hossain, D. M. et al. Leukemia cell-targeted STAT3 silencing and TLR9 triggering generate systemic antitumor immunity. Blood 123, 15\u201325 (2014).","journal-title":"Blood"},{"key":"7820_CR43","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1038\/s41586-020-2708-8","volume":"586","author":"K. H Dinnon 3rd","year":"2020","unstructured":"Dinnon, K. H. 3rd et al. A mouse-adapted model of SARS-CoV-2 to test COVID-19 countermeasures. Nature 586, 560\u2013566 (2020).","journal-title":"Nature"},{"key":"7820_CR44","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1146\/annurev-immunol-101320-020220","volume":"42","author":"S. N Christo","year":"2024","unstructured":"Christo, S. N., Park, S. L., Mueller, S. N. & Mackay, L. K. The multifaceted role of tissue-resident memory T Cells. Annu. Rev. Immunol. 42, 317\u2013345 (2024).","journal-title":"Annu. Rev. Immunol."},{"key":"7820_CR45","doi-asserted-by":"publisher","first-page":"eabf6692","DOI":"10.1126\/sciimmunol.abf6692","volume":"6","author":"Y Zhao","year":"2021","unstructured":"Zhao, Y. et al. Clonal expansion and activation of tissue-resident memory-like Th17 cells expressing GM-CSF in the lungs of severe COVID-19 patients. Sci. Immunol. 6, eabf6692 (2021).","journal-title":"Sci. Immunol."},{"key":"7820_CR46","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abe4782","volume":"6","author":"A Kusnadi","year":"2021","unstructured":"Kusnadi, A. et al. Severely ill COVID-19 patients display impaired exhaustion features in SARS-CoV-2-reactive CD8+ T cells. Sci. Immunol. 6, eabe4782 (2021).","journal-title":"Sci. Immunol."},{"key":"7820_CR47","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1038\/s41586-021-03569-1","volume":"595","author":"J. C Melms","year":"2021","unstructured":"Melms, J. C. et al. A molecular single-cell lung atlas of lethal COVID-19. Nature 595, 114\u2013119 (2021).","journal-title":"Nature"},{"key":"7820_CR48","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/s41586-021-03570-8","volume":"595","author":"T. M Delorey","year":"2021","unstructured":"Delorey, T. M. et al. COVID-19 tissue atlases reveal SARS-CoV-2 pathology and cellular targets. Nature 595, 107\u2013113 (2021).","journal-title":"Nature"},{"key":"7820_CR49","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.immuni.2006.01.015","volume":"24","author":"D. J Zammit","year":"2006","unstructured":"Zammit, D. J., Turner, D. L., Klonowski, K. D., Lefran\u00e7ois, L. & Cauley, L. S. Residual antigen presentation after influenza virus infection affects CD8 T cell activation and migration. Immunity 24, 439\u2013449 (2006).","journal-title":"Immunity"},{"key":"7820_CR50","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1084\/jem.20092017","volume":"207","author":"T. S Kim","year":"2010","unstructured":"Kim, T. S., Hufford, M. M., Sun, J., Fu, Y. X. & Braciale, T. J. Antigen persistence and the control of local T cell memory by migrant respiratory dendritic cells after acute virus infection. J. Exp. Med. 207, 1161\u20131172 (2010).","journal-title":"J. Exp. Med."},{"key":"7820_CR51","doi-asserted-by":"publisher","first-page":"4694","DOI":"10.1172\/JCI138554","volume":"130","author":"A Mazzoni","year":"2020","unstructured":"Mazzoni, A. et al. Impaired immune cell cytotoxicity in severe COVID-19 is IL-6 dependent.  J. Clin. Investig. 130, 4694\u20134703 (2020).","journal-title":"J. Clin. Investig."},{"key":"7820_CR52","first-page":"e23010","volume":"2","author":"C R\u00e9b\u00e9","year":"2013","unstructured":"R\u00e9b\u00e9, C., V\u00e9gran, F., Berger, H. & Ghiringhelli, F. STAT3 activation: a key factor in tumor immunoescape. Jakstat 2, e23010 (2013).","journal-title":"Jakstat"},{"key":"7820_CR53","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-01236-6","volume":"8","author":"D Chakraborty","year":"2017","unstructured":"Chakraborty, D. et al. Activation of STAT3 integrates common profibrotic pathways to promote fibroblast activation and tissue fibrosis. Nat. Commun. 8, 1130 (2017).","journal-title":"Nat. Commun."},{"key":"7820_CR54","doi-asserted-by":"publisher","first-page":"2347","DOI":"10.1172\/JCI122462","volume":"130","author":"C Dees","year":"2020","unstructured":"Dees, C. et al. TGF-\u03b2\u2013induced epigenetic deregulation of SOCS3 facilitates STAT3 signaling to promote fibrosis.  J. Clin. Investig. 130, 2347\u20132363 (2020).","journal-title":"J. Clin. Investig."},{"key":"7820_CR55","doi-asserted-by":"publisher","first-page":"657","DOI":"10.4049\/jimmunol.182.1.657","volume":"182","author":"P. L Simonian","year":"2009","unstructured":"Simonian, P. L. et al. Th17-Polarized immune response in a murine model of hypersensitivity pneumonitis and lung fibrosis.  J. Immunol. 182, 657\u2013665 (2009).","journal-title":"J. Immunol."},{"key":"7820_CR56","doi-asserted-by":"publisher","first-page":"3755","DOI":"10.4049\/jimmunol.1302470","volume":"193","author":"T.-T. T Le","year":"2014","unstructured":"Le, T.-T. T. et al. Blockade of IL-6 <em>Trans<\/em> Signaling Attenuates Pulmonary Fibrosis.  J. Immunol. 193, 3755\u20133768 (2014).","journal-title":"J. Immunol."},{"key":"7820_CR57","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.immuni.2013.10.022","volume":"40","author":"C. A Fielding","year":"2014","unstructured":"Fielding, C. A. et al. Interleukin-6 signaling drives fibrosis in unresolved inflammation. Immunity 40, 40\u201350 (2014).","journal-title":"Immunity"},{"key":"7820_CR58","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/S2468-1253(18)30009-8","volume":"3","author":"D. J Jonker","year":"2018","unstructured":"Jonker, D. J. et al. Napabucasin versus placebo in refractory advanced colorectal cancer: a randomised phase 3 trial. Lancet Gastroenterol. Hepatol. 3, 263\u2013270 (2018).","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"7820_CR59","doi-asserted-by":"publisher","first-page":"5887","DOI":"10.1158\/1078-0432.CCR-20-1803","volume":"26","author":"A Kawazoe","year":"2020","unstructured":"Kawazoe, A. et al. Multicenter Phase I\/II Trial of Napabucasin and Pembrolizumab in Patients with Metastatic Colorectal Cancer (EPOC1503\/SCOOP Trial). Clin. Cancer Res. 26, 5887\u20135894 (2020).","journal-title":"Clin. Cancer Res."},{"key":"7820_CR60","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-020-01258-7","volume":"19","author":"S Zou","year":"2020","unstructured":"Zou, S. et al. Targeting STAT3 in cancer immunotherapy. Mol. Cancer 19, 145 (2020).","journal-title":"Mol. Cancer"},{"key":"7820_CR61","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.it.2011.10.005","volume":"33","author":"K. J Oestreich","year":"2012","unstructured":"Oestreich, K. J. & Weinmann, A. S. T-bet employs diverse regulatory mechanisms to repress transcription. Trends Immunol. 33, 78\u201383 (2012).","journal-title":"Trends Immunol."},{"key":"7820_CR62","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.immuni.2014.02.005","volume":"40","author":"J. P Ray","year":"2014","unstructured":"Ray, J. P. et al. Transcription factor STAT3 and type I interferons are corepressive insulators for differentiation of follicular helper and T helper 1 cells. Immunity 40, 367\u2013377 (2014).","journal-title":"Immunity"},{"key":"7820_CR63","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1016\/j.immuni.2011.09.016","volume":"35","author":"A. M Siegel","year":"2011","unstructured":"Siegel, A. M. et al. A critical role for STAT3 transcription factor signaling in the development and maintenance of human T cell memory. Immunity 35, 806\u2013818 (2011).","journal-title":"Immunity"},{"key":"7820_CR64","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.coi.2018.03.017","volume":"51","author":"J. J Milner","year":"2018","unstructured":"Milner, J. J. & Goldrath, A. W. Transcriptional programming of tissue-resident memory CD8(+) T cells. Curr. Opin. Immunol. 51, 162\u2013169 (2018).","journal-title":"Curr. Opin. Immunol."},{"key":"7820_CR65","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1016\/j.immuni.2019.03.028","volume":"50","author":"W. J Leonard","year":"2019","unstructured":"Leonard, W. J., Lin, J. X. & O\u2019Shea, J. J. The gammac family of cytokines: basic biology to therapeutic ramifications. Immunity 50, 832\u2013850 (2019).","journal-title":"Immunity"},{"key":"7820_CR66","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2021.624483","volume":"11","author":"F. J Gil-Etayo","year":"2021","unstructured":"Gil-Etayo, F. J. et al. T-Helper cell subset response is a determining factor in COVID-19 progression. Front. Cell Infect. Microbiol. 11, 624483 (2021).","journal-title":"Front. Cell Infect. Microbiol."},{"key":"7820_CR67","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1007\/s00277-020-04066-7","volume":"99","author":"L Roncati","year":"2020","unstructured":"Roncati, L., Nasillo, V., Lusenti, B. & Riva, G. Signals of Th2 immune response from COVID-19 patients requiring intensive care. Ann. Hematol. 99, 1419\u20131420 (2020).","journal-title":"Ann. Hematol."},{"key":"7820_CR68","doi-asserted-by":"publisher","first-page":"e142032","DOI":"10.1172\/jci.insight.142032","volume":"5","author":"J. W Golden","year":"2020","unstructured":"Golden, J. W. et al. Human angiotensin-converting enzyme 2 transgenic mice infected with SARS-CoV-2 develop severe and fatal respiratory disease. JCI Insight 5, e142032 (2020).","journal-title":"JCI Insight"},{"key":"7820_CR69","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1038\/s41590-020-0778-2","volume":"21","author":"E. S Winkler","year":"2020","unstructured":"Winkler, E. S. et al. SARS-CoV-2 infection of human ACE2-transgenic mice causes severe lung inflammation and impaired function. Nat. Immunol. 21, 1327\u20131335 (2020).","journal-title":"Nat. Immunol."},{"key":"7820_CR70","doi-asserted-by":"publisher","first-page":"e167306","DOI":"10.1172\/jci.insight.167306","volume":"8","author":"T Tada","year":"2023","unstructured":"Tada, T., Peng, J. Y., Dcosta, B. M. & Landau, N. R. Single-epitope T cell-based vaccine protects against SARS-CoV-2 infection in a preclinical animal model. JCI Insight 8, e167306 (2023).","journal-title":"JCI Insight"},{"key":"7820_CR71","doi-asserted-by":"publisher","first-page":"e172488","DOI":"10.1172\/jci.insight.172488","volume":"8","author":"J van Bergen","year":"2023","unstructured":"van Bergen, J. et al. Multiantigen pan-sarbecovirus DNA vaccines generate protective T cell immune responses. JCI Insight 8, e172488 (2023).","journal-title":"JCI Insight"},{"key":"7820_CR72","doi-asserted-by":"publisher","first-page":"e155789","DOI":"10.1172\/jci.insight.155789","volume":"9","author":"J Shi","year":"2024","unstructured":"Shi, J. et al. A T cell-based SARS-CoV-2 spike protein vaccine provides protection without antibodies. JCI Insight 9, e155789 (2024).","journal-title":"JCI Insight"},{"key":"7820_CR73","first-page":"A1764","volume":"11","author":"J Xie","year":"2023","unstructured":"Xie, J. & Heath, J. 1539 SARS-CoV-2 genome-wide single-chain-trimer peptide-MHCs reveal CD8+ T cell landscape in COVID-19 patients and distinct TCR repertoire dynamics. J. ImmunoTherapy Cancer 11, A1764\u2013A1764 (2023).","journal-title":"J. ImmunoTherapy Cancer"},{"key":"7820_CR74","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2020.100095","volume":"1","author":"C. B Marinaik","year":"2020","unstructured":"Marinaik, C. B. et al. Programming multifaceted pulmonary T cell immunity by combination adjuvants. Cell Rep. Med. 1, 100095 (2020).","journal-title":"Cell Rep. Med."},{"key":"7820_CR75","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/0042-6822(88)90471-0","volume":"162","author":"J. L Whitton","year":"1988","unstructured":"Whitton, J. L., Southern, P. J. & Oldstone, M. B. Analyses of the cytotoxic T lymphocyte responses to glycoprotein and nucleoprotein components of lymphocytic choriomeningitis virus. Virology 162, 321\u2013327 (1988).","journal-title":"Virology"},{"key":"7820_CR76","doi-asserted-by":"publisher","first-page":"4414","DOI":"10.4049\/jimmunol.154.9.4414","volume":"154","author":"N. P Restifo","year":"1995","unstructured":"Restifo, N. P. et al. Antigen processing in vivo and the elicitation of primary CTL responses. J. Immunol. 154, 4414\u20134422 (1995).","journal-title":"J. Immunol."}],"container-title":["Communications Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-07820-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-07820-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-07820-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,8]],"date-time":"2025-03-08T18:11:31Z","timestamp":1741457491000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-07820-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,8]]},"references-count":76,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7820"],"URL":"https:\/\/doi.org\/10.1038\/s42003-025-07820-7","relation":{},"ISSN":["2399-3642"],"issn-type":[{"value":"2399-3642","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,8]]},"assertion":[{"value":"15 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"392"}}